Showing results (181-190 of 516) with videos related to

Sort By:
Pageof 52
International Journal of Antimicrobial Agents|May 9, 2026
Multidrug-Resistant Enterobacterales in United States Hospitals: Frequency and Susceptibility to Newer β-Lactamase Inhibitor Combinations (2020-2024)Helio S Sader, Rodrigo E Mendes, John H Kimbrough, et al.
Antibiotics (Basel, Switzerland)|April 27, 2026
Antimicrobial Susceptibility of Pseudomonas aeruginosa from Elderly Patients in Intensive Care Units of United States Medical Centers (2021-2025)Helio S Sader, Rodrigo E Mendes, Timothy B Doyle, et al.
Diagnostic Microbiology and Infectious Disease|October 21, 2021
Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018-2020)Helio S Sader, Rodrigo E Mendes, Jennifer M Streit, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 2010
Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008)Mariana Castanheira, Amy A Watters, Rodrigo E Mendes, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 15, 2009
Clonal dissemination of two clusters of Acinetobacter baumannii producing OXA-23 or OXA-58 in Rome, ItalyR E Mendes, T Spanu, L Deshpande, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 14, 2009
Dissemination and genetic context analysis of bla(VIM-6) among Pseudomonas aeruginosa isolates in Asian-Pacific NationsM Castanheira, J M Bell, J D Turnidge, et al.
The Journal of Antimicrobial Chemotherapy|August 30, 2021
Increasing frequency of OXA-48-producing Enterobacterales worldwide and activity of ceftazidime/avibactam, meropenem/vaborbactam and comparators against these isolatesMariana Castanheira, Timothy B Doyle, Timothy D Collingsworth, et al.
Pageof 52